NCT00104338View on ClinicalTrials.gov

Study of FK778 in Renal Transplant Recipients With Untreated BK Nephropathy

PHASE2TerminatedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

August 31, 2006

Conditions
BK PolyomavirusKidney Diseases
Interventions
DRUG

FK778

Trial Locations (21)

17104

Harrisburg

20010

Washington D.C.

21287

Baltimore

22031

Fairfax

22710

Durham

30322

Atlanta

32216

Jacksonville

32610

Gainesville

38014

Memphis

45267

Cincinnati

60612

Chicago

60637

Chicago

67214

Wichita

80262

Denver

84132

Salt Lake City

90057

Los Angeles

90095

Los Angeles

92123

San Diego

94115

San Francisco

94143

San Francisco

08901

New Brunswick

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma US, Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY